Our Technology

Engineering Fit-for-Purpose Biotherapeutics

Rooted in protein modeling and structure-guided engineering.

Leveraging industry-leading expertise in the fields of protein engineering and drug chemistry facilitates our ability to discover and develop next-generation antibody-based therapeutics to combat unmet medical need such as hard-to-treat cancers.

Integration of complementary and antibody-based technologies, embedded in our proprietary Multispecific and ADC therapeutic modalities, interfaced with disease biology, enables development of differentiated and fit-for-purpose therapeutics.

Select Difficult-to-Treat Cancers & Target

Design with Complementary Technology

Optionality with Two Foundational Fit-for-Purpose Modalities